DE60035434D1 - Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken - Google Patents

Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken

Info

Publication number
DE60035434D1
DE60035434D1 DE60035434T DE60035434T DE60035434D1 DE 60035434 D1 DE60035434 D1 DE 60035434D1 DE 60035434 T DE60035434 T DE 60035434T DE 60035434 T DE60035434 T DE 60035434T DE 60035434 D1 DE60035434 D1 DE 60035434D1
Authority
DE
Germany
Prior art keywords
epitop
libraries
selection
binding compounds
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60035434T
Other languages
English (en)
Other versions
DE60035434T2 (de
Inventor
Ton Logtenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Vaccines and Prevention BV
Original Assignee
Crucell Holand BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holand BV filed Critical Crucell Holand BV
Publication of DE60035434D1 publication Critical patent/DE60035434D1/de
Application granted granted Critical
Publication of DE60035434T2 publication Critical patent/DE60035434T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]
DE60035434T 1999-12-27 2000-12-21 Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken Expired - Lifetime DE60035434T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204561 1999-12-27
EP99204561 1999-12-27
PCT/NL2000/000941 WO2001048485A2 (en) 1999-12-27 2000-12-21 Selecting library members capable of binding to epitopes

Publications (2)

Publication Number Publication Date
DE60035434D1 true DE60035434D1 (de) 2007-08-16
DE60035434T2 DE60035434T2 (de) 2008-05-15

Family

ID=8241110

Family Applications (3)

Application Number Title Priority Date Filing Date
DE60033455T Expired - Lifetime DE60033455T2 (de) 1999-12-27 2000-12-21 Menschlischer monoklonaler Antikörper gegen Ep-CAM und dessen Verwendung in Krebstherapie
DE60038132T Expired - Lifetime DE60038132T2 (de) 1999-12-27 2000-12-21 Antikörper gegen Ep-Cam
DE60035434T Expired - Lifetime DE60035434T2 (de) 1999-12-27 2000-12-21 Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE60033455T Expired - Lifetime DE60033455T2 (de) 1999-12-27 2000-12-21 Menschlischer monoklonaler Antikörper gegen Ep-CAM und dessen Verwendung in Krebstherapie
DE60038132T Expired - Lifetime DE60038132T2 (de) 1999-12-27 2000-12-21 Antikörper gegen Ep-Cam

Country Status (11)

Country Link
US (2) US20030096225A1 (de)
EP (3) EP1242823B1 (de)
JP (1) JP2003518391A (de)
AT (3) ATE366419T1 (de)
AU (1) AU783148B2 (de)
CA (1) CA2396029A1 (de)
DE (3) DE60033455T2 (de)
DK (1) DK1479696T3 (de)
ES (1) ES2282797T3 (de)
NZ (2) NZ520074A (de)
WO (1) WO2001048485A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658924B2 (en) 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
WO2003089671A1 (en) * 2002-04-17 2003-10-30 Roberto Crea 'doping' in walk-through mutagenesis
CN100480260C (zh) 2002-07-18 2009-04-22 克鲁塞尔荷兰公司 抗体混合物的重组生产
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
WO2004106375A1 (en) 2003-05-30 2004-12-09 Merus Biopharmaceuticals B.V. I.O. Fab library for the preparation of anti vegf and anti rabies virus fabs
EP1663118A4 (de) * 2003-09-08 2008-10-15 Du Pont Konditionierer und färbemittel auf peptidbasis für haar, haut und nägel
DK1737971T3 (da) 2004-01-20 2017-11-13 Merus Nv Blandinger af bindingsproteiner
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
US9079942B2 (en) 2009-02-09 2015-07-14 Epitomics, Inc. CDR-anchored amplification method
GB0909904D0 (en) 2009-06-09 2009-07-22 Affitech As Product
US8293483B2 (en) 2009-09-11 2012-10-23 Epitomics, Inc. Method for identifying lineage-related antibodies
US9541480B2 (en) 2011-06-29 2017-01-10 Academia Sinica Capture, purification, and release of biological substances using a surface coating
CA2791109C (en) 2011-09-26 2021-02-16 Merus B.V. Generation of binding molecules
EP2819695B1 (de) * 2012-03-02 2018-06-27 Academia Sinica Antikörper gegen epithelzelladhäsionsmoleküle (epcam) und anwendungsverfahren dafür
NZ772318A (en) 2012-04-20 2023-06-30 Merus Nv Methods and means for the production of ig-like molecules
EP3126814B1 (de) 2014-04-01 2019-06-12 Academia Sinica Verfahren und system zur diagnose und prognose von krebs
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
WO2019213624A1 (en) * 2018-05-04 2019-11-07 The Regents Of The University Of California Spiked primers for enrichment of pathogen nucleic acids among background of nucleic acids
US11707487B2 (en) 2020-04-13 2023-07-25 Affyimmune Therapeutics, Inc. EpCAM antibody and CAR-T cells
CN116600819A (zh) * 2020-12-09 2023-08-15 艾弗依姆恩治疗公司 靶向epcam和icam-1的双嵌合抗原受体
WO2023174521A1 (en) 2022-03-15 2023-09-21 Genmab A/S Binding agents binding to epcam and cd137

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6265150B1 (en) * 1995-06-07 2001-07-24 Becton Dickinson & Company Phage antibodies
JP2001512560A (ja) * 1996-10-08 2001-08-21 ユー―ビスイス ベスローテン フェンノートシャップ 標的に対し特異的な親和性を有するペプチドおよびタンパク質の選択のための方法および手段
US6787638B1 (en) * 1998-12-02 2004-09-07 Applied Molecular Evolution, Inc. Tumor specific human monoclonal antibodies and methods of use

Also Published As

Publication number Publication date
AU783148B2 (en) 2005-09-29
WO2001048485A9 (en) 2002-09-06
EP1273918B1 (de) 2008-02-20
US7777010B2 (en) 2010-08-17
JP2003518391A (ja) 2003-06-10
DE60038132D1 (de) 2008-04-03
US20030096225A1 (en) 2003-05-22
EP1479696B1 (de) 2007-02-14
EP1479696A1 (de) 2004-11-24
ATE386747T1 (de) 2008-03-15
EP1242823A2 (de) 2002-09-25
DE60038132T2 (de) 2009-04-02
US20030096226A1 (en) 2003-05-22
EP1242823B1 (de) 2007-07-04
DE60035434T2 (de) 2008-05-15
EP1273918A3 (de) 2003-05-02
ATE366419T1 (de) 2007-07-15
WO2001048485A3 (en) 2002-01-31
CA2396029A1 (en) 2001-07-05
ES2282797T3 (es) 2007-10-16
AU3244701A (en) 2001-07-09
DE60033455D1 (de) 2007-03-29
ATE353920T1 (de) 2007-03-15
WO2001048485A2 (en) 2001-07-05
EP1273918A2 (de) 2003-01-08
NZ520074A (en) 2004-04-30
DE60033455T2 (de) 2007-11-29
NZ531590A (en) 2006-01-27
DK1479696T3 (da) 2007-05-07

Similar Documents

Publication Publication Date Title
DE60035434D1 (de) Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
WO2002086083A3 (en) Methods of enhancing cell responsiveness
WO2003061570A3 (en) Engineered binding proteins
WO2003029458A3 (de) Verfahren zur herstellung von protein-bibliotheken und zur selektion von proteinen daraus
NL194720B (nl) Werkwijze ter vervaardiging van een asymmetrisch membraan.
TR200001313T2 (tr) Protein etkileşimlerini ve fonksiyonel ilişkileri kaydeden tarama sistemleri
PT1001265E (pt) Frasco para amostras
PT868427E (pt) Metodos para identificar compostos que se ligam a um alvo
ES1027962Y (es) Vial para reactivos quimicos.
NL1002590A1 (nl) Draaginrichting voor een muziekinstrument.
WO2001038566A3 (en) Screening method for candidate drugs
AU4749497A (en) Binding proteins for phosphoinositides, grp1 or general receptor 1 for phosphoinositide
NL1008621A1 (nl) Werkwijze voor het vervaardigen van een halfgeleiderelement.
DK0774116T3 (da) Fremgangsmåde til screening af biblioteker af forbindelser
DK1328657T3 (da) Proces til påvisning af serin-/threoninkinaseaktivitet
DE59809534D1 (de) Verfahren zur Bearbeitung von Zapfen an Tripoden
NL193235B (nl) Bevestigingsklemstuk voor een voetstuk van een schakelkast.
WO2002072761A3 (en) Polypeptides interactive with bcl-x¿l?
WO2001088847A3 (en) Lead molecule generation
BR0007149A (pt) Sistema de telecarregamento de arquivos de dados em vários computadores embarcados a bordo de um veìculo automóvel
NL1000361A1 (nl) Inrichting voor het in werking stellen van een klinkorgaan van een patroon.
WO2000073345A3 (en) Antibodies specific for mycobacterial polypeptides and uses thereof
DE29803615U1 (de) Tonabnehmersystem für elektrische-Seiteninstrumente (z.B. Elektrogitarre) bestehend aus Tonabnehmersockel mit herausnehmbarem (schnell wechselbarem) Tonabnehmer, sowie verschiedene Varianten und Extras für diese zwei Komponenten
WO2003012721A3 (en) Prediction models for molecular activity and protein binding
TR199600579A2 (tr) N-N-Dietil-8,8-Dipropil-2-Azaspiro (4.5) Dekan-2-propanamid dimaleat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition